Sentence examples for intermediate risk score of from inspiring English sources

However, within node-positive luminal A tumors, some patients with the low and intermediate risk score of GHI had a DRFS at 8.5 years >90%.

Among the normoglycemic participants with an intermediate risk score of 10 19, 7.6% of distressed and 6.0% of nondistressed people had type 2 diabetes at follow-up; the confidence intervals suggesting no association with psychological distress.

6 In patients with intermediate-risk (score of 1), acetylsalicylic acid (ASA) may be used although warfarin is still preferred.

For patients with an intermediate-risk score of 1, options of anticoagulation, aspirin, or no therapy are left to the discretion of the provider (class IIb).

Three strata of risk were defined (low risk, score 0 to 2; intermediate risk, score 3 to 5; and high risk, score >/=6) with excellent prognostic accuracy for survival in the derivation and validation sets (c statistics = 0.83 and 0.81 for 30-day mortality and 0.79 and 0.78 for 1-year mortality, respectively).

The Sokal risk scores were designated as follows: low Sokal risk (score <0.8); intermediate risk (score 0.8 1.2); and high Sokal risk (score >1.2).

The Hasford risk score was designated as follows: low Hasford risk (score ≤780); intermediate risk (score 781 1480); and high risk (score >1480).

Independent prognostic factors for locoregional relapse included N2 3 stage, GTV-p ≥26.8 mL, and involvement of one or more structures within cluster 3. We calculated a risk score derived from the regression coefficient of each factor and classified patients into four groups: low risk (score 0), intermediate risk (score >0 and ≤1), high risk (score >1 and ≤2), and extremely high risk (score >2).

Three of these patients did not undergo genomic assessment, and the other patient had an intermediate risk score and was not on a clinical trial.

VTV was 3.9 cm3 for low risk; intermediate risk scored patients showed an average VTV of 4.7 ± 2.5 cm3 (range 2.3 8.9 cm3).

The clinical performance was particularly high in patients at intermediate risk (Gleason score of 7) and in samples containing high tumor cell content.